Loading clinical trials...
Loading clinical trials...
Observational, Prospective, Multicenter Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)
Conditions
Interventions
Histoacryl®
Start Date
February 1, 2026
Primary Completion Date
December 1, 2026
Completion Date
August 1, 2027
Last Updated
February 12, 2026
NCT06163547
NCT05374681
NCT07324551
NCT05649904
NCT06759428
NCT06724029
Lead Sponsor
Aesculap AG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions